Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlo Colosimo

Showing results (141-150 of 168) with videos related to

Pageof 17
Sort By:
Journal of Neurochemistry|September 8, 2023
Cerebrospinal fluid and blood serum biomarkers in neurodegenerative proteinopathies: A prospective, open, cross-correlation studyDorota Koníčková, Kateřina Menšíková, Kateřina Klíčová, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 2, 2012
The Unified Multiple System Atrophy Rating Scale: intrarater reliabilityFlorian Krismer, Klaus Seppi, François Tison, et al.
Parkinsonism & Related Disorders|October 19, 2020
Adapting to post-COVID19 research in Parkinson's disease: Lessons from a multinational experienceEng-King Tan, Alberto Albanese, KRay Chaudhuri, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|August 13, 2011
Psychosis associated to Parkinson's disease in the early stages: relevance of cognitive decline and depressionLetterio Morgante, Carlo Colosimo, Angelo Antonini, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 14, 2017
Radiological biomarkers for diagnosis in PSP: Where are we and where do we need to be?Jennifer L Whitwell, Günter U Höglinger, Angelo Antonini, et al.
Nature Reviews. Neurology|February 9, 2024
Reply to: Questioning the cycad theory of Kii ALS-PDC causationKaterina Menšíková, Raymond Rosales, Carlo Colosimo, et al.
Nature Reviews. Neurology|September 8, 2023
Endemic parkinsonism: clusters, biology and clinical featuresKaterina Menšíková, John C Steele, Raymond Rosales, et al.
Journal of Neurology|February 10, 2018
Defining spasticity: a new approach considering current movement disorders terminology and botulinum toxin therapyDirk Dressler, Roongroj Bhidayasiri, Saeed Bohlega, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 29, 2021
A Modified Progressive Supranuclear Palsy Rating ScaleMarie-Therese Grötsch, Gesine Respondek, Carlo Colosimo, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|February 26, 2021
Consensus guidelines for botulinum toxin therapy: general algorithms and dosing tables for dystonia and spasticityDirk Dressler, Maria Concetta Altavista, Eckart Altenmueller, et al.
Pageof 17

Showing results (141-150 of 168) with videos related to

Sort By:
Pageof 17
Journal of Neurochemistry|September 8, 2023
Cerebrospinal fluid and blood serum biomarkers in neurodegenerative proteinopathies: A prospective, open, cross-correlation studyDorota Koníčková, Kateřina Menšíková, Kateřina Klíčová, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 2, 2012
The Unified Multiple System Atrophy Rating Scale: intrarater reliabilityFlorian Krismer, Klaus Seppi, François Tison, et al.
Parkinsonism & Related Disorders|October 19, 2020
Adapting to post-COVID19 research in Parkinson's disease: Lessons from a multinational experienceEng-King Tan, Alberto Albanese, KRay Chaudhuri, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|August 13, 2011
Psychosis associated to Parkinson's disease in the early stages: relevance of cognitive decline and depressionLetterio Morgante, Carlo Colosimo, Angelo Antonini, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 14, 2017
Radiological biomarkers for diagnosis in PSP: Where are we and where do we need to be?Jennifer L Whitwell, Günter U Höglinger, Angelo Antonini, et al.
Nature Reviews. Neurology|February 9, 2024
Reply to: Questioning the cycad theory of Kii ALS-PDC causationKaterina Menšíková, Raymond Rosales, Carlo Colosimo, et al.
Nature Reviews. Neurology|September 8, 2023
Endemic parkinsonism: clusters, biology and clinical featuresKaterina Menšíková, John C Steele, Raymond Rosales, et al.
Journal of Neurology|February 10, 2018
Defining spasticity: a new approach considering current movement disorders terminology and botulinum toxin therapyDirk Dressler, Roongroj Bhidayasiri, Saeed Bohlega, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 29, 2021
A Modified Progressive Supranuclear Palsy Rating ScaleMarie-Therese Grötsch, Gesine Respondek, Carlo Colosimo, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|February 26, 2021
Consensus guidelines for botulinum toxin therapy: general algorithms and dosing tables for dystonia and spasticityDirk Dressler, Maria Concetta Altavista, Eckart Altenmueller, et al.
Pageof 17